Advisor Group, Inc. - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 113 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q4 2019$1,000210.0%0.00%
Q3 2019$0
-100.0%
21
-91.9%
0.00%
Q2 2019$6,000
-14.3%
258
+6.2%
0.00%
Q1 2019$7,000
+16.7%
2430.0%0.00%
Q4 2018$6,000
-25.0%
243
+2.5%
0.00%
Q3 2018$8,000
-11.1%
237
-19.1%
0.00%
Q2 2018$9,000
-10.0%
293
-16.8%
0.00%
Q1 2018$10,000
-44.4%
352
-22.5%
0.00%
Q4 2017$18,0004540.00%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q4 2019
NameSharesValueWeighting ↓
Zeal Asset Management Ltd 2,339,885$93,421,00021.31%
UG Investment Advisers Ltd. 33,155$1,302,0002.52%
Pinz Capital Management, LP 159,400$6,260,0001.88%
Capital International Sarl 547,743$21,510,0001.86%
Capital International, Inc./CA/ 4,391,684$172,461,0001.54%
AIA Group Ltd 437,118$17,380,0001.20%
York Capital Management Global Advisors, LLC 182,297$7,159,0000.80%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 68,000$2,671,0000.70%
E Fund Management (Hong Kong) Co., Ltd. 18,579$730,0000.46%
M&G INVESTMENT MANAGEMENT LTD 4,512,562$175,990,0000.44%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders